The Lancet

The Lancet is a weekly peer-reviewed general medical journal. It is one of the world's best known, oldest, and most respected general medical journals. The Lancet was founded in 1823 by Thomas Wakley, an English surgeon who named it after the surgical instrument called a lancet, as well as after the term "lancet arch", a window with a sharp pointed arch, to indicate the "light of wisdom" or "to let in light". It publishes original research articles, review articles ("seminars" and "reviews"), editorials, book reviews, correspondence, as well as news features and case reports. The Lancet has been owned by Elsevier since 1991. As of 1995, the editor-in-chief is Richard Horton. The journal has editorial offices in London, New York, and Beijing.

Publisher
Elsevier
History
1823 -- present
Impact factor
33.633 (2010)

Some content from Wikipedia, licensed under CC BY-SA

Diseases, Conditions, Syndromes

The importance of timing in restrictive confinement

COVID-19 is revealing invisible ingredients in our contact networks—breath, touching, and physical surfaces. Understanding these networks is key to assessing how infectious diseases spread and how measures to extinguish ...

Diseases, Conditions, Syndromes

COVID-19 vaccine candidate shows promise in first peer-reviewed research

University of Pittsburgh School of Medicine scientists today announced a potential vaccine against SARS-CoV-2, the new coronavirus causing the COVID-19 pandemic. When tested in mice, the vaccine, delivered through a fingertip-sized ...

Diseases, Conditions, Syndromes

Study shows middle-age COVID-19 mortality risk

Middle-aged people, and not just the elderly, have a dramatically higher risk of dying or developing serious illness from COVID-19, new research from Britain showed Tuesday.

Genetics

The genetic quest to understand COVID-19

How the novel coronavirus that causes COVID-19 made the leap from animals to humans is a puzzle that scientists are trying to solve as humanity comes to grip with the deadly pandemic sweeping the globe.

Oncology & Cancer

Chemo ups disease-free survival in upper tract urothelial cancer

(HealthDay)—For patients with locally advanced upper tract urothelial carcinoma (UTUC), gemcitabine-platinum combination chemotherapy improves disease-free survival, according to a study published online March 5 in The ...

page 1 from 46